Project Grant R21DA059919
Award Date
9/1/24
Completion Date
8/31/26
Dollars Obligated
$190K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Winston-Salem, NC 27157, USA
Similar Awards
This $492,000 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) supports a multi-year research project at the University of Chicago. The project aims to elucidate the genetic and epigenetic factors underlying cocaine addiction through a multidimensional approach integrating genomics, epigenomics, neuroscience, and computational biology. Key objectives include: 1) Conducting high-resolution chromatin accessibility...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $249,236 to Duke University to study the chromatin regulation of brain-derived neurotrophic factor (BDNF) in cocaine craving and relapse. The project aims to use innovative molecular genetic methods to define the chromatin architecture changes in dopamine neurons that accompany persistent alterations in gene expression, specifically focused on...
This $158,024 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research to investigate the role of the GILZ gene in regulating cocaine-induced cellular activity and cocaine-associated memory formation. The research, to be conducted at the University of California Irvine, aims to test the hypothesis that the GILZ gene, located on the X chromosome, acts in the nucleus accumbens region of the brain...
This federal Project Grant award, valued at $1,478,199.00 and funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to investigate the differential roles of prefrontal cortical interneurons in drug-seeking behavior after withdrawal from cocaine. The primary objectives are to: 1) monitor the activity of distinct interneuron subtypes in the infralimbic cortex during cocaine self-administration, 2) directly...
This federal Project Grant award, valued at $136,929.00 and issued by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research on the circuit mechanisms underlying inflexible habitual behaviors following chronic cocaine use. The research objectives include: 1) Determining how a history of cocaine self-administration alters dopamine release and neural activity patterns to promote habitual behavior; 2) Investigating how cocaine...
This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $658,750.00 to Wake Forest University Health Sciences (WFUHS) to fund a research project titled "Viral Vectors for Desensitization-Resistant nAChRs". The goal of the project is to design, produce, and validate adeno-associated viral (AAV) vectors for expressing desensitization-resistant nicotinic acetylcholine receptor (nAChR) subunits, and...
This federal Project Grant award for $671,981.00 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant will fund research to investigate the role of cortical excitatory projections in cocaine addiction, with a focus on the supplementary motor cortex (M2) and its connections to the dorsolateral striatum. The 5-year project aims to 1) examine the excitability of pyramidal neurons in the M2 region, 2) assess...
This federal Project Grant award in the amount of $149,284 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research at Vanderbilt University to define how chronic cocaine use disrupts the dopaminergic control of striatal activity. The research aims to 1) establish the precise temporal conditions under which dopamine modulates the activity of genetically-defined medium spiny neuron populations in the nucleus...
This federal Project Grant award, totaling $346,911, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award, valid from August 15, 2024 to July 31, 2026, will support a cross-species study to identify neurocognitive, genetic, and socioenvironmental risk factors for substance use disorders (SUDs). The key objectives of the project are to: 1) determine how early life environment influences neurocognitive development...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $251,250 to the University of Massachusetts Medical School (UMass Medical) to conduct exploratory research on the role of the neuropeptide nociceptin (N/OFQ) in suppressing cocaine reward in the mesolimbic brain region. The funded project aims to characterize the mechanisms and circuitry by which N/OFQ signaling in the nucleus accumbens can...